Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
About Us
Home
>
About Us
>
Corporate Governance
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Corporate Governance
Nyrada 2022 Appendix 4G and Corporate Governance Statement
The Company By-Laws
Board Charter
Remuneration and Nomination Committee Charter
Anti-Bribery and Corruption Policy
Audit and Risk Committee Charter
Board Skills Summary
Communication and Disclosure Policy
Risk Management Policy
Diversity Policy
Securities Trading Policy
Code of Conduct
Certificate of Incorporation
Whistleblower Policy
Values Statement
